Caribou Biosciences
NASDAQ: CRBU
Pioneering CRISPR genome editing for new medical therapies.
Investment Team
Sector
Life SciencesCategory
TherapeuticsLocation
Berkeley, CAInitial Investment
2015
Pioneering CRISPR genome editing for new medical therapies.
Caribou (NASDAQ: CRBU) is a leading company in CRISPR genome editing founded by pioneers of CRISPR-Cas9 biology. Caribou’s proprietary technologies put the company at the forefront of the development of new medical therapies.